olaptesed pegol
1 product
1 abstract
Abstract
Potential predictive biomarker for response to radiotherapy and CXCL12 inhibition in glioblastoma in the phase I/II GLORIA trial.Org: University Medical Center Mannheim, University of Heidelberg, University Hospital Bonn, University Hospital Leipzig, Heidelberg University Hospital, Heidelberg, Germany,
Product
Olaptesed pegol